Bowers added that to increase access to the latest drugs, the "cancer system" must be organized in such a way as to ...

Today we highlight research findings reported at ESMO 2024, the annual meeting of the European Society of Medical Oncology.

Before the annual congress of the European Society for Medical Oncology began in Barcelona, clinicians held a press ...

From combining treatments in unprecedented ways to deploying artificial intelligence for personalized medicine, a raft of new ...

Professors Tom Powles and Peter Schmid recently delivered results from their phase three clinical trials during Sunday's ...

Breastfeeding is feasible for patients with hormone receptor–positive breast cancer who are undergoing a break of endocrine ...

For patients with advanced melanoma, there is a survival benefit for nivolumab plus ipilimumab and for nivolumab monotherapy ...

Wall Street apparently wanted more from Prelude Therapeutics Inc.’s phase I data with SMARCA2 enzyme degrader PRT-3789 in ...

Metastatic solid tumors may be curable now. Among the most profound results presented over the weekend at the European ...

Exelixis releases positive phase 3 data on Cabometyx for pancreatic and extra-pancreatic neuroendocrine tumors, seeking ...

CG Oncology stock is up 7% following bladder cancer data released by Johnson & Johnson. Read more here.